<DOC>
	<DOCNO>NCT00136695</DOCNO>
	<brief_summary>The purpose study assess effect sustain aromatase inhibitor therapy reduce estrogen level elderly men mild hypogonadism ( decrease level sex hormone ) .</brief_summary>
	<brief_title>Anastrozole Administration Elderly Hypogonadal Men</brief_title>
	<detailed_description>It long accept age men associate slow , steady decline gonadal androgen ( male sex hormone ) production . Several study explore androgen replacement , safety efficacy testosterone administration remain controversial . Aromatase inhibitor may provide particularly useful way restore normal androgen production age men . This study recruit 150 male volunteer , 60 year age old , randomize receive either anastrozole placebo 24 month . Six visit plan 96-week treatment period .</detailed_description>
	<mesh_term>Hypogonadism</mesh_term>
	<mesh_term>Anastrozole</mesh_term>
	<criteria>Men age 60 old Serum testosterone 150300 ng/dL Symptoms suggestive androgen deficiency</criteria>
	<gender>Male</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Aging</keyword>
</DOC>